
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2025
16 new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended 16 medicines for approval at its April 2025 meeting. The CHMP recommended granting a marketing authorisation for Alyftrek* (deutivacaftor / tezacaftor / …